Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
3.540
+0.350 (10.97%)
At close: Jul 19, 2024, 4:00 PM
3.590
+0.050 (1.41%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Daré Bioscience Revenue

Daré Bioscience had revenue of $2.82M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $9.30K. In the year 2023, Daré Bioscience had annual revenue of $2.81M.

Revenue (ttm)
$2.82M
Revenue Growth
-71.83%
P/S Ratio
10.59
Revenue / Employee
$108,353
Employees
26
Market Cap
29.82M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.81M-7.19M-71.92%
Dec 31, 202210.00M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 201480.00K74.00K1,233.33%
Dec 31, 20136.00K-619.00K-99.04%
Dec 31, 2012625.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareCloud 113.02M
Rapid Micro Biosystems 23.10M
Streamline Health Solutions 21.59M
Spectral AI 19.30M
Evogene 9.19M
Lipocine 4.71M
Pluri 341.00K
Revenue Rankings